Pyridine-appended disulfidephospholipids enable exceptionally high drug loading and stability as a robust liposomal platform
Source abstract
Abstract
Low drug loading and instability of liposomes are two main challenges in the clinic. Herein, a liposomal platform from alternative pyridine-appended disulfidephospholipid (Pyr-SS-PC) was developed for delivering camptothecin (CPT) with high loading and stability. These Pyr-SS-PC lipids with π-π stacking open a general gate in the delivery of aromatic ring-containing drugs.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Lipid Membrane Structure and Behavior
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Key Laboratory of Molecular Pharmacology and Drug Evaluation (Ministry of Education of China), School of Pharmacy, Yantai University, Yantai 264005, China
Funding
Natural Science Foundation of Shandong Province
References (29)
Show source-provided references
1. Cheng · Angew. Chem., Int. Ed. · 2014 · 53 · 1392810.1002/anie.201408934 ↗
2. Van Meer · Nat. Rev. Mol. Cell Biol. · 2008 · 9 · 11210.1038/nrm2330 ↗
3. Allen · Adv. Drug Delivery Rev. · 2013 · 65 · 3610.1016/j.addr.2012.09.037 ↗
4. Torchilin · Nat. Rev. Drug Discovery · 2005 · 4 · 14510.1038/nrd1632 ↗
5. Eloy · Colloids Surf., B · 2014 · 123 · 34510.1016/j.colsurfb.2014.09.029 ↗
6. Shah · Adv. Drug Delivery Rev. · 2020 · 154 · 10210.1016/j.addr.2020.07.002 ↗
7. Joo · Biomaterials · 2013 · 34 · 309810.1016/j.biomaterials.2013.01.039 ↗
8. Deng · Sci. Adv. · 2020 · 6 · eaax997610.1126/sciadv.aax9976 ↗
9. Song · Angew. Chem., Int. Ed. · 2005 · 44 · 473110.1002/anie.200500980 ↗
10. Zhuang · J. Controlled Release · 2019 · 294 · 31110.1016/j.jconrel.2018.12.014 ↗
11. Ling · Int. J. Pharm. · 2017 · 526 · 1110.1016/j.ijpharm.2017.04.024 ↗
12. Ling · Chem. Commun. · 2020 · 56 · 762110.1039/D0CC03589K ↗
13. Liu · Nano Lett. · 2021 · 21 · 786210.1021/acs.nanolett.1c03089 ↗
14. Robby · Nano Today · 2021 · 39 · 10117810.1016/j.nantod.2021.101178 ↗
15. Zhang · New J. Chem. · 2019 · 43 · 1867310.1039/C9NJ05052C ↗
16. Bom · J. Med. Chem. · 2000 · 43 · 397010.1021/jm000144o ↗
17. Watanabe · J. Controlled Release · 2008 · 127 · 23110.1016/j.jconrel.2008.02.005 ↗
18. Carter · Nat. Commun. · 2014 · 5 · 110.1038/ncomms4546 ↗
19. Lyubartsev · Eur. Biophys. J. · 2005 · 35 · 5310.1007/s00249-005-0005-y ↗
20. Huang · Angew. Chem., Int. Ed. · 2009 · 121 · 421010.1002/ange.200900111 ↗
21. Moon · Nat. Mater. · 2011 · 10 · 24310.1038/nmat2960 ↗
22. Sivadasan · Molecules · 2022 · 27 · 108610.3390/molecules27031086 ↗
23. Watanabe · J. Controlled Release · 2008 · 127 · 23110.1016/j.jconrel.2008.02.005 ↗
24. Liang · Adv. Mater. · 2018 · 30 · 170696310.1002/adma.201706963 ↗
25. Luzio · Nat. Rev. Mol. Cell Biol. · 2007 · 8 · 62210.1038/nrm2217 ↗
26. Von Kleist · Cell · 2011 · 146 · 47110.1016/j.cell.2011.06.025 ↗
27. Wang · Cell Res. · 2008 · 18 · 29010.1038/cr.2008.15 ↗
28. Zhang · Angew. Chem., Int. Ed. · 2019 · 131 · 1393210.1002/ange.201907380 ↗
29. Freyer · Br. J. Cancer · 2000 · 83 · 43110.1054/bjoc.2000.1303 ↗